Takahashi Hideo Kohka, Iwagaki Hiromi, Hamano Ryosuke, Yoshino Tadashi, Tanaka Noriaki, Nishibori Masahiro
Department of Pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science, Japan.
J Pharmacol Sci. 2006 Sep;102(1):143-6. doi: 10.1254/jphs.sc0060074. Epub 2006 Sep 8.
Nicotine inhibited interleukin (IL)-18 and -12 production in lipopolysaccharide (LPS)-stimulated monocytes, and the action of nicotine was antagonized by a non-selective and a selective alpha7 nicotinic acetylcholine receptor (alpha7-nAChR) antagonist, suggesting that the stimulation of alpha7-nAChR may be involved in the action of nicotine. Nicotine is reported to induce prostaglandin E(2) (PGE(2)) production in monocytes through the up-regulation of cyclooxygenase (COX)-2 expression. PGE(2) is known to increase cAMP levels and to activate protein kinase A (PKA). COX-2 and PKA inhibitors prevented the action of nicotine, indicating that the mechanism of action of nicotine may be via endogenous PGE(2) production.
尼古丁抑制脂多糖(LPS)刺激的单核细胞中白细胞介素(IL)-18和-12的产生,且尼古丁的作用被非选择性和选择性α7烟碱型乙酰胆碱受体(α7-nAChR)拮抗剂拮抗,这表明α7-nAChR的刺激可能参与尼古丁的作用。据报道,尼古丁通过上调环氧化酶(COX)-2的表达诱导单核细胞中前列腺素E2(PGE2)的产生。已知PGE2可增加cAMP水平并激活蛋白激酶A(PKA)。COX-2和PKA抑制剂可阻止尼古丁的作用,表明尼古丁的作用机制可能是通过内源性PGE2的产生。